Additional European Equity News

Bellway (BWY LN) - Trading Update: On track to deliver FY26 underlying operating profit within the previously guided range of GBP 320-330mln. Confirms robust performance; however the outlook beyond the current financial year remains uncertain. (Bellway)

BP (BP/ LN) - The Co.'s top investors and former executives have expressed concerns that the Co. may lose momentum over the cost-cutting and restructuring plans driven by former CEO Manifold, with some shareholders still in the dark about the precise circumstances that led to the firing of Manifold, the FT reports. (FT)

GSK (GSK LN) - Co. confirms the acquisition of Nuvalent (NUVL) for USD 10.6bln. GSK says the acquisition is consistent with its strategy, with the deal including 3 projects in lung cancer. Furthermore, the Co. backs its 2026 view, seeing 2026 EPS growth between 7-9% and expects the acquisition to contribute to revenue growth from 2027. (GSK)

K+S (SDF GY) -  Co. launches offering of c. EUR 300mln convertible bonds, due 2031. (K+S)

Nordex (NDX1 GY) - Co. secures a new order totalling 155MW in SE Turkey. (Nordex)

Peab (PEABB SS) - Co. awarded a SEK 348mln contract to carry out a complete renovation of a central meeting place at Campus Umea. (Peab)

Relx (REL LN) - Co. authorises GBP 200mln non-discretionary share buyback programme. (Relx)

Renault (RNO FP) - Co. is reportedly aiming to cap revenue from drone manufacturing and other defence ventures at 5%, the FT reports. (FT)

Saab (SAABB SS) - Co. has agreed to sell its public safety solutions operations to Norway's Omda. Omda to pay SEK 15mln upfront, in addition to an earn-out component of up to SEK 45mln (Saab)

Sweco AB (SWECB SS) - Co. agrees to acquire Sitowise Sverige; no terms disclosed. (Sweco AB)

Givaudan (GIVN SW) upgraded to Buy from Hold at Deutsche Bank.